Anzeige
Erschienen in:
01.12.2021 | Short Communication
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset
Erschienen in: Archives of Osteoporosis | Ausgabe 1/2021
Einloggen, um Zugang zu erhaltenAbstract
Summary
In the present observational cohort study in 4902 men and 9804 women, we found that the factors associated with osteoporosis care utilization in men were comorbidities, adjuvant hormonal therapy for prostate cancer, vertebral or hip fractures, and glucocorticoid treatment.
Introduction
Male osteoporosis is associated with an important clinical and economic burden worldwide; nevertheless, undertreatment of men with osteoporosis is common. Understanding the factors associated with referral to bone specialists may help to define future interventions to improve access to osteoporosis care for male patients.
Methods
We conducted a retrospective analysis of a nationwide cohort (DeFRACalc79 database). DeFRACalc79 is a tool that estimates the fracture risk by considering clinical and densitometric risk factors, including the presence of prior hip or vertebral and non-vertebral or non-hip fractures. We compared the clinical characteristics of male individuals with an age-matched cohort of women. Propensity score generation with a 2:1 female-to-male ratio was performed using a logistic regression model to age-match the cohorts.
Results
We analyzed a sample of 4902 men at high risk for osteoporosis. We found that the factors associated with osteoporosis care utilization in men were the presence of comorbidities (OR 1.939, 95% CI 1.799–2.090), adjuvant hormonal therapy for prostate cancer (OR 1.482, 95% CI 1.315–1.670), the presence of vertebral or hip fractures (OR 1.490, 95% CI 1.378–1.611), and glucocorticoid treatment (OR 2.573, 95% CI 2.274–2.832).
Conclusions
Men are more commonly referred to the bone specialist with a prevalent fragility fracture and/or diagnosis of secondary osteoporosis as compared with women. Our study suggests that there is a lack of screening for the primary prevention of osteoporosis in men as compared with that in women.